|
MO19-2 INSIGHT2: Tepotinib + osimertinib in pts with EGFR-mutant NSCLC and acquired resistance to 1L osimertinib due to METamp |
|
|
|
Titel: |
MO19-2 INSIGHT2: Tepotinib + osimertinib in pts with EGFR-mutant NSCLC and acquired resistance to 1L osimertinib due to METamp |
Auteur: |
Morise, Masahiro Sakai, Hiroshi Kato, Terufumi Tokito, Takaaki Takeda, Masayuki Tanaka, Hiroshi Chikamori, Kenichi Daga, Haruko Kijima, Takashi Ohashi, Kadoaki Karachaliou, Niki Ellers-Lenz, Barbara Wu, Yi-Long |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 32 () nr. S4 pagina's S309 |
Jaar: |
2021 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|